ASND - Ascendis Pharma A/S

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts4465
Avg. Estimate-0.93-0.91-3.85-3.93
Low Estimate-1.05-0.99-4.22-4.96
High Estimate-0.72-0.72-2.87-2.11
Year Ago EPS-0.96-1.15-4.51-3.85
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts4465
Avg. Estimate500k500k3.87M3.34M
Low EstimateN/AN/A980kN/A
High Estimate1.39M1.39M12.24M12.24M
Year Ago Sales455.48k543.64k1.87M3.87M
Sales Growth (year/est)9.80%-8.00%106.60%-13.70%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.82-0.88-0.9-0.98
EPS Actual-0.96-1.15-1.27-1.13
Difference-0.14-0.27-0.37-0.15
Surprise %-17.10%-30.70%-41.10%-15.30%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.93-0.91-3.85-3.93
7 Days Ago-0.93-0.91-3.85-3.93
30 Days Ago-0.89-0.89-3.75-4.4
60 Days Ago-0.93-0.94-3.96-4.65
90 Days Ago-0.94-0.95-3.87-4.62
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1132
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesASNDIndustrySectorS&P 500
Current Qtr.3.10%N/AN/A0.42
Next Qtr.20.90%N/AN/A0.39
Current Year14.60%N/AN/A0.20
Next Year-2.10%N/AN/A0.10
Next 5 Years (per annum)24.00%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A